Global SGLT2 Inhibitors Production, Demand and Key Producers, 2022-2028
This report studies the global SGLT2 Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for SGLT2 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of SGLT2 Inhibitors that contribute to its increasing demand across many markets.
The global SGLT2 Inhibitors market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global SGLT2 Inhibitors total production and demand, 2017-2028, (Tablets)
Global SGLT2 Inhibitors total production value, 2017-2028, (USD Million)
Global SGLT2 Inhibitors production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Tablets)
Global SGLT2 Inhibitors consumption by region & country, CAGR, 2017-2028 & (Tablets)
U.S. VS China: SGLT2 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global SGLT2 Inhibitors production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Tablets)
Global SGLT2 Inhibitors production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Tablets)
Global SGLT2 Inhibitors production by Application production, value, CAGR, 2017-2028, (USD Million) & (Tablets)
This reports profiles key players in the global SGLT2 Inhibitors market based on the following parameters – headquarters, production locations, products portfolio, SGLT2 Inhibitors revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World SGLT2 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tablets) and average price (US$/Tablets) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global SGLT2 Inhibitors Market, By Region:
1. How big is the global SGLT2 Inhibitors market?
2. What is the demand of the global SGLT2 Inhibitors market?
3. What is the year over year growth of the global SGLT2 Inhibitors market?
4. What is the production and production value of the global SGLT2 Inhibitors market?
5. Who are the key producers in the global SGLT2 Inhibitors market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for SGLT2 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of SGLT2 Inhibitors that contribute to its increasing demand across many markets.
The global SGLT2 Inhibitors market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global SGLT2 Inhibitors total production and demand, 2017-2028, (Tablets)
Global SGLT2 Inhibitors total production value, 2017-2028, (USD Million)
Global SGLT2 Inhibitors production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Tablets)
Global SGLT2 Inhibitors consumption by region & country, CAGR, 2017-2028 & (Tablets)
U.S. VS China: SGLT2 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global SGLT2 Inhibitors production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Tablets)
Global SGLT2 Inhibitors production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Tablets)
Global SGLT2 Inhibitors production by Application production, value, CAGR, 2017-2028, (USD Million) & (Tablets)
This reports profiles key players in the global SGLT2 Inhibitors market based on the following parameters – headquarters, production locations, products portfolio, SGLT2 Inhibitors revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World SGLT2 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tablets) and average price (US$/Tablets) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global SGLT2 Inhibitors Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Canagliflozin
- Dapagliflozin
- Canagliflozin
- Other
- Single Drug
- Combination Medication
- AstraZeneca
- Hengrui Medicine
- Johnson and Johnson
- Kelun Pharmaceutical
- Chia Tai-Tianqing Pharmaceutical
- Hansoh Pharmaceutical Group
- Orifarm
- Starpharma
- Sandoz
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Merck
1. How big is the global SGLT2 Inhibitors market?
2. What is the demand of the global SGLT2 Inhibitors market?
3. What is the year over year growth of the global SGLT2 Inhibitors market?
4. What is the production and production value of the global SGLT2 Inhibitors market?
5. Who are the key producers in the global SGLT2 Inhibitors market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 SGLT2 Inhibitors Introduction
1.2 World SGLT2 Inhibitors Supply & Forecast
1.2.1 World SGLT2 Inhibitors Production Value (2017 & 2021 & 2028)
1.2.2 World SGLT2 Inhibitors Production (2017-2028)
1.2.3 World SGLT2 Inhibitors Pricing Trends (2017-2028)
1.3 World SGLT2 Inhibitors Production by Region
1.3.1 World SGLT2 Inhibitors Production Value by Region (2017-2028)
1.3.2 World SGLT2 Inhibitors Production by Region (2017-2028)
1.3.3 World SGLT2 Inhibitors Average Price by Region (2017-2028)
1.3.4 North America SGLT2 Inhibitors Production (2017-2028)
1.3.5 Europe SGLT2 Inhibitors Production (2017-2028)
1.3.6 China SGLT2 Inhibitors Production (2017-2028)
1.3.7 Japan SGLT2 Inhibitors Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 SGLT2 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 SGLT2 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World SGLT2 Inhibitors Demand (2017-2028)
2.2 World SGLT2 Inhibitors Consumption by Region
2.2.1 World SGLT2 Inhibitors Consumption by Region (2017-2022)
2.2.2 World SGLT2 Inhibitors Consumption Forecast by Region (2023-2028)
2.3 United States SGLT2 Inhibitors Consumption (2017-2028)
2.4 China SGLT2 Inhibitors Consumption (2017-2028)
2.5 Europe SGLT2 Inhibitors Consumption (2017-2028)
2.6 Japan SGLT2 Inhibitors Consumption (2017-2028)
2.7 South Korea SGLT2 Inhibitors Consumption (2017-2028)
2.8 ASEAN SGLT2 Inhibitors Consumption (2017-2028)
2.9 India SGLT2 Inhibitors Consumption (2017-2028)
3 WORLD SGLT2 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World SGLT2 Inhibitors Production Value by Manufacturer (2017-2022)
3.2 World SGLT2 Inhibitors Production by Manufacturer (2017-2022)
3.3 World SGLT2 Inhibitors Average Price by Manufacturer (2017-2022)
3.4 SGLT2 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global SGLT2 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for SGLT2 Inhibitors in 2021
3.5.3 Global Concentration Ratios (CR8) for SGLT2 Inhibitors in 2021
3.6 SGLT2 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 SGLT2 Inhibitors Market: Region Footprint
3.6.2 SGLT2 Inhibitors Market: Company Product Type Footprint
3.6.3 SGLT2 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: SGLT2 Inhibitors Production Value Comparison
4.1.1 United States VS China: SGLT2 Inhibitors Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: SGLT2 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: SGLT2 Inhibitors Production Comparison
4.2.1 United States VS China: SGLT2 Inhibitors Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: SGLT2 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: SGLT2 Inhibitors Consumption Comparison
4.3.1 United States VS China: SGLT2 Inhibitors Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: SGLT2 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States SGLT2 Inhibitors Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of SGLT2 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.5 China SGLT2 Inhibitors Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of SGLT2 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World SGLT2 Inhibitors Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of SGLT2 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World SGLT2 Inhibitors Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Canagliflozin
5.2.2 Dapagliflozin
5.2.3 Canagliflozin
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World SGLT2 Inhibitors Production by Type (2017-2028)
5.3.2 World SGLT2 Inhibitors Production Value by Type (2017-2028)
5.3.3 World SGLT2 Inhibitors Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SGLT2 Inhibitors Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Single Drug
6.2.2 Combination Medication
6.3 Market Segment by Application
6.3.1 World SGLT2 Inhibitors Production by Application (2017-2028)
6.3.2 World SGLT2 Inhibitors Production Value by Application (2017-2028)
6.3.3 World SGLT2 Inhibitors Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Details
7.1.2 AstraZeneca Major Business
7.1.3 AstraZeneca SGLT2 Inhibitors Product and Services
7.1.4 AstraZeneca SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 AstraZeneca Recent Developments/Updates
7.1.6 AstraZeneca Competitive Strengths & Weaknesses
7.2 Hengrui Medicine
7.2.1 Hengrui Medicine Details
7.2.2 Hengrui Medicine Major Business
7.2.3 Hengrui Medicine SGLT2 Inhibitors Product and Services
7.2.4 Hengrui Medicine SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Hengrui Medicine Recent Developments/Updates
7.2.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Details
7.3.2 Johnson and Johnson Major Business
7.3.3 Johnson and Johnson SGLT2 Inhibitors Product and Services
7.3.4 Johnson and Johnson SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Johnson and Johnson Recent Developments/Updates
7.3.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.4 Kelun Pharmaceutical
7.4.1 Kelun Pharmaceutical Details
7.4.2 Kelun Pharmaceutical Major Business
7.4.3 Kelun Pharmaceutical SGLT2 Inhibitors Product and Services
7.4.4 Kelun Pharmaceutical SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Kelun Pharmaceutical Recent Developments/Updates
7.4.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.5 Chia Tai-Tianqing Pharmaceutical
7.5.1 Chia Tai-Tianqing Pharmaceutical Details
7.5.2 Chia Tai-Tianqing Pharmaceutical Major Business
7.5.3 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product and Services
7.5.4 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
7.5.6 Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
7.6 Hansoh Pharmaceutical Group
7.6.1 Hansoh Pharmaceutical Group Details
7.6.2 Hansoh Pharmaceutical Group Major Business
7.6.3 Hansoh Pharmaceutical Group SGLT2 Inhibitors Product and Services
7.6.4 Hansoh Pharmaceutical Group SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Hansoh Pharmaceutical Group Recent Developments/Updates
7.6.6 Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
7.7 Orifarm
7.7.1 Orifarm Details
7.7.2 Orifarm Major Business
7.7.3 Orifarm SGLT2 Inhibitors Product and Services
7.7.4 Orifarm SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Orifarm Recent Developments/Updates
7.7.6 Orifarm Competitive Strengths & Weaknesses
7.8 Starpharma
7.8.1 Starpharma Details
7.8.2 Starpharma Major Business
7.8.3 Starpharma SGLT2 Inhibitors Product and Services
7.8.4 Starpharma SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Starpharma Recent Developments/Updates
7.8.6 Starpharma Competitive Strengths & Weaknesses
7.9 Sandoz
7.9.1 Sandoz Details
7.9.2 Sandoz Major Business
7.9.3 Sandoz SGLT2 Inhibitors Product and Services
7.9.4 Sandoz SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Sandoz Recent Developments/Updates
7.9.6 Sandoz Competitive Strengths & Weaknesses
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Details
7.10.2 Bristol-Myers Squibb Major Business
7.10.3 Bristol-Myers Squibb SGLT2 Inhibitors Product and Services
7.10.4 Bristol-Myers Squibb SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Bristol-Myers Squibb Recent Developments/Updates
7.10.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Details
7.11.2 Boehringer Ingelheim Major Business
7.11.3 Boehringer Ingelheim SGLT2 Inhibitors Product and Services
7.11.4 Boehringer Ingelheim SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Boehringer Ingelheim Recent Developments/Updates
7.11.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.12 Merck
7.12.1 Merck Details
7.12.2 Merck Major Business
7.12.3 Merck SGLT2 Inhibitors Product and Services
7.12.4 Merck SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Merck Recent Developments/Updates
7.12.6 Merck Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of SGLT2 Inhibitors and Key Manufacturers
8.2 SGLT2 Inhibitors Manufacturing Costs
8.3 SGLT2 Inhibitors Production Process
8.4 SGLT2 Inhibitors Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for SGLT2 Inhibitors Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 SGLT2 Inhibitors Typical Distributors
9.3 SGLT2 Inhibitors Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 SGLT2 Inhibitors Introduction
1.2 World SGLT2 Inhibitors Supply & Forecast
1.2.1 World SGLT2 Inhibitors Production Value (2017 & 2021 & 2028)
1.2.2 World SGLT2 Inhibitors Production (2017-2028)
1.2.3 World SGLT2 Inhibitors Pricing Trends (2017-2028)
1.3 World SGLT2 Inhibitors Production by Region
1.3.1 World SGLT2 Inhibitors Production Value by Region (2017-2028)
1.3.2 World SGLT2 Inhibitors Production by Region (2017-2028)
1.3.3 World SGLT2 Inhibitors Average Price by Region (2017-2028)
1.3.4 North America SGLT2 Inhibitors Production (2017-2028)
1.3.5 Europe SGLT2 Inhibitors Production (2017-2028)
1.3.6 China SGLT2 Inhibitors Production (2017-2028)
1.3.7 Japan SGLT2 Inhibitors Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 SGLT2 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 SGLT2 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World SGLT2 Inhibitors Demand (2017-2028)
2.2 World SGLT2 Inhibitors Consumption by Region
2.2.1 World SGLT2 Inhibitors Consumption by Region (2017-2022)
2.2.2 World SGLT2 Inhibitors Consumption Forecast by Region (2023-2028)
2.3 United States SGLT2 Inhibitors Consumption (2017-2028)
2.4 China SGLT2 Inhibitors Consumption (2017-2028)
2.5 Europe SGLT2 Inhibitors Consumption (2017-2028)
2.6 Japan SGLT2 Inhibitors Consumption (2017-2028)
2.7 South Korea SGLT2 Inhibitors Consumption (2017-2028)
2.8 ASEAN SGLT2 Inhibitors Consumption (2017-2028)
2.9 India SGLT2 Inhibitors Consumption (2017-2028)
3 WORLD SGLT2 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World SGLT2 Inhibitors Production Value by Manufacturer (2017-2022)
3.2 World SGLT2 Inhibitors Production by Manufacturer (2017-2022)
3.3 World SGLT2 Inhibitors Average Price by Manufacturer (2017-2022)
3.4 SGLT2 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global SGLT2 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for SGLT2 Inhibitors in 2021
3.5.3 Global Concentration Ratios (CR8) for SGLT2 Inhibitors in 2021
3.6 SGLT2 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 SGLT2 Inhibitors Market: Region Footprint
3.6.2 SGLT2 Inhibitors Market: Company Product Type Footprint
3.6.3 SGLT2 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: SGLT2 Inhibitors Production Value Comparison
4.1.1 United States VS China: SGLT2 Inhibitors Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: SGLT2 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: SGLT2 Inhibitors Production Comparison
4.2.1 United States VS China: SGLT2 Inhibitors Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: SGLT2 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: SGLT2 Inhibitors Consumption Comparison
4.3.1 United States VS China: SGLT2 Inhibitors Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: SGLT2 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States SGLT2 Inhibitors Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of SGLT2 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.5 China SGLT2 Inhibitors Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of SGLT2 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World SGLT2 Inhibitors Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of SGLT2 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World SGLT2 Inhibitors Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Canagliflozin
5.2.2 Dapagliflozin
5.2.3 Canagliflozin
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World SGLT2 Inhibitors Production by Type (2017-2028)
5.3.2 World SGLT2 Inhibitors Production Value by Type (2017-2028)
5.3.3 World SGLT2 Inhibitors Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SGLT2 Inhibitors Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Single Drug
6.2.2 Combination Medication
6.3 Market Segment by Application
6.3.1 World SGLT2 Inhibitors Production by Application (2017-2028)
6.3.2 World SGLT2 Inhibitors Production Value by Application (2017-2028)
6.3.3 World SGLT2 Inhibitors Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Details
7.1.2 AstraZeneca Major Business
7.1.3 AstraZeneca SGLT2 Inhibitors Product and Services
7.1.4 AstraZeneca SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 AstraZeneca Recent Developments/Updates
7.1.6 AstraZeneca Competitive Strengths & Weaknesses
7.2 Hengrui Medicine
7.2.1 Hengrui Medicine Details
7.2.2 Hengrui Medicine Major Business
7.2.3 Hengrui Medicine SGLT2 Inhibitors Product and Services
7.2.4 Hengrui Medicine SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Hengrui Medicine Recent Developments/Updates
7.2.6 Hengrui Medicine Competitive Strengths & Weaknesses
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Details
7.3.2 Johnson and Johnson Major Business
7.3.3 Johnson and Johnson SGLT2 Inhibitors Product and Services
7.3.4 Johnson and Johnson SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Johnson and Johnson Recent Developments/Updates
7.3.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.4 Kelun Pharmaceutical
7.4.1 Kelun Pharmaceutical Details
7.4.2 Kelun Pharmaceutical Major Business
7.4.3 Kelun Pharmaceutical SGLT2 Inhibitors Product and Services
7.4.4 Kelun Pharmaceutical SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Kelun Pharmaceutical Recent Developments/Updates
7.4.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.5 Chia Tai-Tianqing Pharmaceutical
7.5.1 Chia Tai-Tianqing Pharmaceutical Details
7.5.2 Chia Tai-Tianqing Pharmaceutical Major Business
7.5.3 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product and Services
7.5.4 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
7.5.6 Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
7.6 Hansoh Pharmaceutical Group
7.6.1 Hansoh Pharmaceutical Group Details
7.6.2 Hansoh Pharmaceutical Group Major Business
7.6.3 Hansoh Pharmaceutical Group SGLT2 Inhibitors Product and Services
7.6.4 Hansoh Pharmaceutical Group SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Hansoh Pharmaceutical Group Recent Developments/Updates
7.6.6 Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
7.7 Orifarm
7.7.1 Orifarm Details
7.7.2 Orifarm Major Business
7.7.3 Orifarm SGLT2 Inhibitors Product and Services
7.7.4 Orifarm SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Orifarm Recent Developments/Updates
7.7.6 Orifarm Competitive Strengths & Weaknesses
7.8 Starpharma
7.8.1 Starpharma Details
7.8.2 Starpharma Major Business
7.8.3 Starpharma SGLT2 Inhibitors Product and Services
7.8.4 Starpharma SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Starpharma Recent Developments/Updates
7.8.6 Starpharma Competitive Strengths & Weaknesses
7.9 Sandoz
7.9.1 Sandoz Details
7.9.2 Sandoz Major Business
7.9.3 Sandoz SGLT2 Inhibitors Product and Services
7.9.4 Sandoz SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Sandoz Recent Developments/Updates
7.9.6 Sandoz Competitive Strengths & Weaknesses
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Details
7.10.2 Bristol-Myers Squibb Major Business
7.10.3 Bristol-Myers Squibb SGLT2 Inhibitors Product and Services
7.10.4 Bristol-Myers Squibb SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Bristol-Myers Squibb Recent Developments/Updates
7.10.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Details
7.11.2 Boehringer Ingelheim Major Business
7.11.3 Boehringer Ingelheim SGLT2 Inhibitors Product and Services
7.11.4 Boehringer Ingelheim SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Boehringer Ingelheim Recent Developments/Updates
7.11.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.12 Merck
7.12.1 Merck Details
7.12.2 Merck Major Business
7.12.3 Merck SGLT2 Inhibitors Product and Services
7.12.4 Merck SGLT2 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Merck Recent Developments/Updates
7.12.6 Merck Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of SGLT2 Inhibitors and Key Manufacturers
8.2 SGLT2 Inhibitors Manufacturing Costs
8.3 SGLT2 Inhibitors Production Process
8.4 SGLT2 Inhibitors Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for SGLT2 Inhibitors Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 SGLT2 Inhibitors Typical Distributors
9.3 SGLT2 Inhibitors Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World SGLT2 Inhibitors Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World SGLT2 Inhibitors Production Value by Region (2017-2022) & (USD Million)
Table 3. World SGLT2 Inhibitors Production Value by Region (2023-2028) & (USD Million)
Table 4. World SGLT2 Inhibitors Production Value Market Share by Region (2017-2022)
Table 5. World SGLT2 Inhibitors Production Value Market Share by Region (2023-2028)
Table 6. World SGLT2 Inhibitors Production by Region (2017-2022) & (Tablets)
Table 7. World SGLT2 Inhibitors Production by Region (2023-2028) & (Tablets)
Table 8. World SGLT2 Inhibitors Production Market Share by Region (2017-2022)
Table 9. World SGLT2 Inhibitors Production Market Share by Region (2023-2028)
Table 10. World SGLT2 Inhibitors Average Price by Region (2017-2022) & (US$/Tablets)
Table 11. World SGLT2 Inhibitors Average Price by Region (2023-2028) & (US$/Tablets)
Table 12. SGLT2 Inhibitors Major Market Trends
Table 13. World SGLT2 Inhibitors Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Tablets)
Table 14. World SGLT2 Inhibitors Consumption by Region (2017-2022) & (Tablets)
Table 15. World SGLT2 Inhibitors Consumption Forecast by Region (2023-2028) & (Tablets)
Table 16. World SGLT2 Inhibitors Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key SGLT2 Inhibitors Producers in 2021
Table 18. World SGLT2 Inhibitors Production by Manufacturer (2017-2022) & (Tablets)
Table 19. Production Market Share of Key SGLT2 Inhibitors Producers in 2021
Table 20. World SGLT2 Inhibitors Average Price by Manufacturer (2017-2022) & (US$/Tablets)
Table 21. Global SGLT2 Inhibitors Company Evaluation Quadrant
Table 22. World SGLT2 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and SGLT2 Inhibitors Production Site of Key Manufacturer
Table 24. SGLT2 Inhibitors Market: Company Product Type Footprint
Table 25. SGLT2 Inhibitors Market: Company Product Application Footprint
Table 26. SGLT2 Inhibitors Competitive Factors
Table 27. SGLT2 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. SGLT2 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China SGLT2 Inhibitors Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China SGLT2 Inhibitors Production Comparison, (2017 & 2021 & 2028) & (Tablets)
Table 31. United States VS China SGLT2 Inhibitors Consumption Comparison, (2017 & 2021 & 2028) & (Tablets)
Table 32. Major Manufacturer of SGLT2 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States SGLT2 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (Tablets)
Table 36. United States SGLT2 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of SGLT2 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
Table 38. China SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China SGLT2 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (Tablets)
Table 41. China SGLT2 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of SGLT2 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World SGLT2 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (Tablets)
Table 46. Rest of World SGLT2 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World SGLT2 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World SGLT2 Inhibitors Production by Type (2017-2022) & (Tablets)
Table 49. World SGLT2 Inhibitors Production by Type (2023-2028) & (Tablets)
Table 50. World SGLT2 Inhibitors Production Value by Type (2017-2022) & (USD Million)
Table 51. World SGLT2 Inhibitors Production Value by Type (2023-2028) & (USD Million)
Table 52. World SGLT2 Inhibitors Average Price by Type (2017-2022) & (US$/Tablets)
Table 53. World SGLT2 Inhibitors Average Price by Type (2023-2028) & (US$/Tablets)
Table 54. World SGLT2 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World SGLT2 Inhibitors Production by Application (2017-2022) & (Tablets)
Table 56. World SGLT2 Inhibitors Production by Application (2023-2028) & (Tablets)
Table 57. World SGLT2 Inhibitors Production Value by Application (2017-2022) & (USD Million)
Table 58. World SGLT2 Inhibitors Production Value by Application (2023-2028) & (USD Million)
Table 59. World SGLT2 Inhibitors Average Price by Application (2017-2022) & (US$/Tablets)
Table 60. World SGLT2 Inhibitors Average Price by Application (2023-2028) & (US$/Tablets)
Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Major Business
Table 63. AstraZeneca SGLT2 Inhibitors Product and Services
Table 64. AstraZeneca SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. AstraZeneca Recent Developments/Updates
Table 66. AstraZeneca Competitive Strengths & Weaknesses
Table 67. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 68. Hengrui Medicine Major Business
Table 69. Hengrui Medicine SGLT2 Inhibitors Product and Services
Table 70. Hengrui Medicine SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Hengrui Medicine Recent Developments/Updates
Table 72. Hengrui Medicine Competitive Strengths & Weaknesses
Table 73. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson and Johnson Major Business
Table 75. Johnson and Johnson SGLT2 Inhibitors Product and Services
Table 76. Johnson and Johnson SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Johnson and Johnson Recent Developments/Updates
Table 78. Johnson and Johnson Competitive Strengths & Weaknesses
Table 79. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Kelun Pharmaceutical Major Business
Table 81. Kelun Pharmaceutical SGLT2 Inhibitors Product and Services
Table 82. Kelun Pharmaceutical SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Kelun Pharmaceutical Recent Developments/Updates
Table 84. Kelun Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Chia Tai-Tianqing Pharmaceutical Major Business
Table 87. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product and Services
Table 88. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 90. Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Hansoh Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 92. Hansoh Pharmaceutical Group Major Business
Table 93. Hansoh Pharmaceutical Group SGLT2 Inhibitors Product and Services
Table 94. Hansoh Pharmaceutical Group SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Hansoh Pharmaceutical Group Recent Developments/Updates
Table 96. Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
Table 97. Orifarm Basic Information, Manufacturing Base and Competitors
Table 98. Orifarm Major Business
Table 99. Orifarm SGLT2 Inhibitors Product and Services
Table 100. Orifarm SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Orifarm Recent Developments/Updates
Table 102. Orifarm Competitive Strengths & Weaknesses
Table 103. Starpharma Basic Information, Manufacturing Base and Competitors
Table 104. Starpharma Major Business
Table 105. Starpharma SGLT2 Inhibitors Product and Services
Table 106. Starpharma SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Starpharma Recent Developments/Updates
Table 108. Starpharma Competitive Strengths & Weaknesses
Table 109. Sandoz Basic Information, Manufacturing Base and Competitors
Table 110. Sandoz Major Business
Table 111. Sandoz SGLT2 Inhibitors Product and Services
Table 112. Sandoz SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Sandoz Recent Developments/Updates
Table 114. Sandoz Competitive Strengths & Weaknesses
Table 115. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 116. Bristol-Myers Squibb Major Business
Table 117. Bristol-Myers Squibb SGLT2 Inhibitors Product and Services
Table 118. Bristol-Myers Squibb SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Bristol-Myers Squibb Recent Developments/Updates
Table 120. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 121. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 122. Boehringer Ingelheim Major Business
Table 123. Boehringer Ingelheim SGLT2 Inhibitors Product and Services
Table 124. Boehringer Ingelheim SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Boehringer Ingelheim Recent Developments/Updates
Table 126. Merck Basic Information, Manufacturing Base and Competitors
Table 127. Merck Major Business
Table 128. Merck SGLT2 Inhibitors Product and Services
Table 129. Merck SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. SGLT2 Inhibitors Raw Material
Table 131. Key Manufacturers of SGLT2 Inhibitors Raw Materials
Table 132. SGLT2 Inhibitors Typical Distributors
Table 133. SGLT2 Inhibitors Typical Customers
Table 1. World SGLT2 Inhibitors Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World SGLT2 Inhibitors Production Value by Region (2017-2022) & (USD Million)
Table 3. World SGLT2 Inhibitors Production Value by Region (2023-2028) & (USD Million)
Table 4. World SGLT2 Inhibitors Production Value Market Share by Region (2017-2022)
Table 5. World SGLT2 Inhibitors Production Value Market Share by Region (2023-2028)
Table 6. World SGLT2 Inhibitors Production by Region (2017-2022) & (Tablets)
Table 7. World SGLT2 Inhibitors Production by Region (2023-2028) & (Tablets)
Table 8. World SGLT2 Inhibitors Production Market Share by Region (2017-2022)
Table 9. World SGLT2 Inhibitors Production Market Share by Region (2023-2028)
Table 10. World SGLT2 Inhibitors Average Price by Region (2017-2022) & (US$/Tablets)
Table 11. World SGLT2 Inhibitors Average Price by Region (2023-2028) & (US$/Tablets)
Table 12. SGLT2 Inhibitors Major Market Trends
Table 13. World SGLT2 Inhibitors Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Tablets)
Table 14. World SGLT2 Inhibitors Consumption by Region (2017-2022) & (Tablets)
Table 15. World SGLT2 Inhibitors Consumption Forecast by Region (2023-2028) & (Tablets)
Table 16. World SGLT2 Inhibitors Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key SGLT2 Inhibitors Producers in 2021
Table 18. World SGLT2 Inhibitors Production by Manufacturer (2017-2022) & (Tablets)
Table 19. Production Market Share of Key SGLT2 Inhibitors Producers in 2021
Table 20. World SGLT2 Inhibitors Average Price by Manufacturer (2017-2022) & (US$/Tablets)
Table 21. Global SGLT2 Inhibitors Company Evaluation Quadrant
Table 22. World SGLT2 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and SGLT2 Inhibitors Production Site of Key Manufacturer
Table 24. SGLT2 Inhibitors Market: Company Product Type Footprint
Table 25. SGLT2 Inhibitors Market: Company Product Application Footprint
Table 26. SGLT2 Inhibitors Competitive Factors
Table 27. SGLT2 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. SGLT2 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China SGLT2 Inhibitors Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China SGLT2 Inhibitors Production Comparison, (2017 & 2021 & 2028) & (Tablets)
Table 31. United States VS China SGLT2 Inhibitors Consumption Comparison, (2017 & 2021 & 2028) & (Tablets)
Table 32. Major Manufacturer of SGLT2 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States SGLT2 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (Tablets)
Table 36. United States SGLT2 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of SGLT2 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
Table 38. China SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China SGLT2 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (Tablets)
Table 41. China SGLT2 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of SGLT2 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World SGLT2 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World SGLT2 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World SGLT2 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (Tablets)
Table 46. Rest of World SGLT2 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World SGLT2 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World SGLT2 Inhibitors Production by Type (2017-2022) & (Tablets)
Table 49. World SGLT2 Inhibitors Production by Type (2023-2028) & (Tablets)
Table 50. World SGLT2 Inhibitors Production Value by Type (2017-2022) & (USD Million)
Table 51. World SGLT2 Inhibitors Production Value by Type (2023-2028) & (USD Million)
Table 52. World SGLT2 Inhibitors Average Price by Type (2017-2022) & (US$/Tablets)
Table 53. World SGLT2 Inhibitors Average Price by Type (2023-2028) & (US$/Tablets)
Table 54. World SGLT2 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World SGLT2 Inhibitors Production by Application (2017-2022) & (Tablets)
Table 56. World SGLT2 Inhibitors Production by Application (2023-2028) & (Tablets)
Table 57. World SGLT2 Inhibitors Production Value by Application (2017-2022) & (USD Million)
Table 58. World SGLT2 Inhibitors Production Value by Application (2023-2028) & (USD Million)
Table 59. World SGLT2 Inhibitors Average Price by Application (2017-2022) & (US$/Tablets)
Table 60. World SGLT2 Inhibitors Average Price by Application (2023-2028) & (US$/Tablets)
Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Major Business
Table 63. AstraZeneca SGLT2 Inhibitors Product and Services
Table 64. AstraZeneca SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. AstraZeneca Recent Developments/Updates
Table 66. AstraZeneca Competitive Strengths & Weaknesses
Table 67. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 68. Hengrui Medicine Major Business
Table 69. Hengrui Medicine SGLT2 Inhibitors Product and Services
Table 70. Hengrui Medicine SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Hengrui Medicine Recent Developments/Updates
Table 72. Hengrui Medicine Competitive Strengths & Weaknesses
Table 73. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson and Johnson Major Business
Table 75. Johnson and Johnson SGLT2 Inhibitors Product and Services
Table 76. Johnson and Johnson SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Johnson and Johnson Recent Developments/Updates
Table 78. Johnson and Johnson Competitive Strengths & Weaknesses
Table 79. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Kelun Pharmaceutical Major Business
Table 81. Kelun Pharmaceutical SGLT2 Inhibitors Product and Services
Table 82. Kelun Pharmaceutical SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Kelun Pharmaceutical Recent Developments/Updates
Table 84. Kelun Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Chia Tai-Tianqing Pharmaceutical Major Business
Table 87. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product and Services
Table 88. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 90. Chia Tai-Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Hansoh Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 92. Hansoh Pharmaceutical Group Major Business
Table 93. Hansoh Pharmaceutical Group SGLT2 Inhibitors Product and Services
Table 94. Hansoh Pharmaceutical Group SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Hansoh Pharmaceutical Group Recent Developments/Updates
Table 96. Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
Table 97. Orifarm Basic Information, Manufacturing Base and Competitors
Table 98. Orifarm Major Business
Table 99. Orifarm SGLT2 Inhibitors Product and Services
Table 100. Orifarm SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Orifarm Recent Developments/Updates
Table 102. Orifarm Competitive Strengths & Weaknesses
Table 103. Starpharma Basic Information, Manufacturing Base and Competitors
Table 104. Starpharma Major Business
Table 105. Starpharma SGLT2 Inhibitors Product and Services
Table 106. Starpharma SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Starpharma Recent Developments/Updates
Table 108. Starpharma Competitive Strengths & Weaknesses
Table 109. Sandoz Basic Information, Manufacturing Base and Competitors
Table 110. Sandoz Major Business
Table 111. Sandoz SGLT2 Inhibitors Product and Services
Table 112. Sandoz SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Sandoz Recent Developments/Updates
Table 114. Sandoz Competitive Strengths & Weaknesses
Table 115. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 116. Bristol-Myers Squibb Major Business
Table 117. Bristol-Myers Squibb SGLT2 Inhibitors Product and Services
Table 118. Bristol-Myers Squibb SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Bristol-Myers Squibb Recent Developments/Updates
Table 120. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 121. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 122. Boehringer Ingelheim Major Business
Table 123. Boehringer Ingelheim SGLT2 Inhibitors Product and Services
Table 124. Boehringer Ingelheim SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Boehringer Ingelheim Recent Developments/Updates
Table 126. Merck Basic Information, Manufacturing Base and Competitors
Table 127. Merck Major Business
Table 128. Merck SGLT2 Inhibitors Product and Services
Table 129. Merck SGLT2 Inhibitors Production (Tablets), Price (US$/Tablets), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. SGLT2 Inhibitors Raw Material
Table 131. Key Manufacturers of SGLT2 Inhibitors Raw Materials
Table 132. SGLT2 Inhibitors Typical Distributors
Table 133. SGLT2 Inhibitors Typical Customers
LIST OF FIGURES
Figure 1. SGLT2 Inhibitors Picture
Figure 2. World SGLT2 Inhibitors Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World SGLT2 Inhibitors Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 5. World SGLT2 Inhibitors Average Price (2017-2028) & (US$/Tablets)
Figure 6. World SGLT2 Inhibitors Production Value Market Share by Region (2017-2028)
Figure 7. World SGLT2 Inhibitors Production Market Share by Region (2017-2028)
Figure 8. North America SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 9. Europe SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 10. China SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 11. Japan SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 12. SGLT2 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World SGLT2 Inhibitors Demand (2017-2028) & (Tablets)
Figure 15. World SGLT2 Inhibitors Consumption Market Share by Region (2017-2028)
Figure 16. United States SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 17. China SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 18. Europe SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 19. Japan SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 20. South Korea SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 21. ASEAN SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 22. India SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 23. Producer Shipments of SGLT2 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for SGLT2 Inhibitors Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for SGLT2 Inhibitors Markets in 2021
Figure 26. United States VS China: SGLT2 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: SGLT2 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: SGLT2 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of SGLT2 Inhibitors in United States
Figure 30. Key Producers and Market Share of SGLT2 Inhibitors in China
Figure 31. Key Producers and Market Share of SGLT2 Inhibitors in Rest of World
Figure 32. World SGLT2 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World SGLT2 Inhibitors Production Value Market Share by Type in 2021
Figure 34. Canagliflozin
Figure 35. Dapagliflozin
Figure 36. Canagliflozin
Figure 37. Other
Figure 38. World SGLT2 Inhibitors Production Market Share by Type (2017-2028)
Figure 39. World SGLT2 Inhibitors Production Value Market Share by Type (2017-2028)
Figure 40. World SGLT2 Inhibitors Average Price by Type (2017-2028) & (US$/Tablets)
Figure 41. World SGLT2 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World SGLT2 Inhibitors Production Value Market Share by Application in 2021
Figure 43. Single Drug
Figure 44. Combination Medication
Figure 45. World SGLT2 Inhibitors Production Market Share by Application (2017-2028)
Figure 46. World SGLT2 Inhibitors Production Value Market Share by Application (2017-2028)
Figure 47. World SGLT2 Inhibitors Average Price by Application (2017-2028) & (US$/Tablets)
Figure 48. Manufacturing Cost Structure Analysis of SGLT2 Inhibitors in 2021
Figure 49. Manufacturing Process Analysis of SGLT2 Inhibitors
Figure 50. SGLT2 Inhibitors Industrial Chain
Figure 51. Distribution Channel Breakdown for SGLT2 Inhibitors Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. SGLT2 Inhibitors Picture
Figure 2. World SGLT2 Inhibitors Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World SGLT2 Inhibitors Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 5. World SGLT2 Inhibitors Average Price (2017-2028) & (US$/Tablets)
Figure 6. World SGLT2 Inhibitors Production Value Market Share by Region (2017-2028)
Figure 7. World SGLT2 Inhibitors Production Market Share by Region (2017-2028)
Figure 8. North America SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 9. Europe SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 10. China SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 11. Japan SGLT2 Inhibitors Production (2017-2028) & (Tablets)
Figure 12. SGLT2 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World SGLT2 Inhibitors Demand (2017-2028) & (Tablets)
Figure 15. World SGLT2 Inhibitors Consumption Market Share by Region (2017-2028)
Figure 16. United States SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 17. China SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 18. Europe SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 19. Japan SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 20. South Korea SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 21. ASEAN SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 22. India SGLT2 Inhibitors Consumption (2017-2028) & (Tablets)
Figure 23. Producer Shipments of SGLT2 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for SGLT2 Inhibitors Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for SGLT2 Inhibitors Markets in 2021
Figure 26. United States VS China: SGLT2 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: SGLT2 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: SGLT2 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of SGLT2 Inhibitors in United States
Figure 30. Key Producers and Market Share of SGLT2 Inhibitors in China
Figure 31. Key Producers and Market Share of SGLT2 Inhibitors in Rest of World
Figure 32. World SGLT2 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World SGLT2 Inhibitors Production Value Market Share by Type in 2021
Figure 34. Canagliflozin
Figure 35. Dapagliflozin
Figure 36. Canagliflozin
Figure 37. Other
Figure 38. World SGLT2 Inhibitors Production Market Share by Type (2017-2028)
Figure 39. World SGLT2 Inhibitors Production Value Market Share by Type (2017-2028)
Figure 40. World SGLT2 Inhibitors Average Price by Type (2017-2028) & (US$/Tablets)
Figure 41. World SGLT2 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World SGLT2 Inhibitors Production Value Market Share by Application in 2021
Figure 43. Single Drug
Figure 44. Combination Medication
Figure 45. World SGLT2 Inhibitors Production Market Share by Application (2017-2028)
Figure 46. World SGLT2 Inhibitors Production Value Market Share by Application (2017-2028)
Figure 47. World SGLT2 Inhibitors Average Price by Application (2017-2028) & (US$/Tablets)
Figure 48. Manufacturing Cost Structure Analysis of SGLT2 Inhibitors in 2021
Figure 49. Manufacturing Process Analysis of SGLT2 Inhibitors
Figure 50. SGLT2 Inhibitors Industrial Chain
Figure 51. Distribution Channel Breakdown for SGLT2 Inhibitors Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
